A Video Tutorial on Thawing, Culturing, and Cryopreserving Human Organoids

Purple and green 488 ck20 organoid cells.

A how-to tutorial for organoid culturing

Step-by-step video tutorial

The currently available preclinical cancer models are often inadequate for studying cancer biology, developing personalized therapeutics, and identifying unique biomarkers. To address this deficit, ATCC has collaborated with the Human Cancer Model Initiative (HCMI) to provide over 200 patient-derived models, including 135 organoids. Watch our tutorial to learn more about next-generation organoid models and to explore step-by-step instructions that thoroughly demonstrate the process of thawing, expanding, and cryopreserving them.

Tutorial: Thawing, Culturing, and Cryopreserving Human Organoids

find organoid models Get the culture guide

Dive into organoid resources

Green and blue conditionally reprogrammed organoid cells.

Human Cancer Models Initiative (HCMI)

ATCC is the exclusive distributor of the Human Cancer Models Initiative (HCMI) models. See the models that include common and rare examples of cancer from numerous tissues.

Blue, pink and green IPS organoid cells.

Organoids

Patient-derived organoids are authenticated cell models paired with genomic and phenotypic data. Organoids are available from the Human Cancer Models Initiative (HCMI) and contribute to valuable and reproducible research.

Culture guide

Organoid Culture Guide

Get expert guidance on growing and maintaining organoids from our organoid culture guide.

Green and red 488 ck20 647 organoid cells.

Blog

The Human Cancer Model Initiative Reaches Key Milestone

We have now provide over 215 advanced cancer models from the NCI and the HCMI to researchers worldwide.

Webinar

Transforming In Vitro Cancer Research With Next-generation Biological Models from the Human Cancer Models Initiative

There is an unmet need for preclinical cancer models that better reflect the genotype and phenotype across the spectrum of cancer found in the patient population. Watch this webinar to hear about the wide variety of patient-derived in vitro cancer models ATCC offers in collaboration with HCMI, including organoids, neurospheres, and conditionally reprogrammed cells.

New HCMI Products

ATCC is the sole distributor for the Human Cancer Models Initiative (HCMI) models. We are adding new models on a monthly basis - stay tuned for new models such as organoids, conditionally reprogrammed cells, and neurospheres.